TGFB1 and cancer: One report demonstrated that the miR-17 ̃92 cluster targets TGF-β signaling, a potential driver of mesenchymal GBM, and therefore over-expression of this miRNA cluster should push cancer cells toward a proneural or epithelial phenotype [38].